{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,25]],"date-time":"2026-10-25T02:56:21Z","timestamp":1792896981882,"version":"4.5.0"},"reference-count":48,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2018,4,17]],"date-time":"2018-04-17T00:00:00Z","timestamp":1523923200000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2018,4,17]],"date-time":"2018-04-17T00:00:00Z","timestamp":1523923200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"funder":[{"DOI":"10.13039\/100000054","name":"National Cancer Institute","doi-asserted-by":"publisher","award":["1F31CA210682-01A1"],"award-info":[{"award-number":["1F31CA210682-01A1"]}],"id":[{"id":"10.13039\/100000054","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000054","name":"National Cancer Institute","doi-asserted-by":"publisher","award":["4T32CA009531-30"],"award-info":[{"award-number":["4T32CA009531-30"]}],"id":[{"id":"10.13039\/100000054","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000054","name":"National Cancer Institute","doi-asserted-by":"publisher","award":["R01CA123451"],"award-info":[{"award-number":["R01CA123451"]}],"id":[{"id":"10.13039\/100000054","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000057","name":"National Institute of General Medical Sciences","doi-asserted-by":"publisher","award":["R25GM058905"],"award-info":[{"award-number":["R25GM058905"]}],"id":[{"id":"10.13039\/100000057","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["P30CA022453"],"award-info":[{"award-number":["P30CA022453"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Neurooncol"],"published-print":{"date-parts":[[2018,9]]},"DOI":"10.1007\/s11060-018-2869-6","type":"journal-article","created":{"date-parts":[[2018,4,17]],"date-time":"2018-04-17T04:46:44Z","timestamp":1523940404000},"page":"239-249","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":52,"title":["Investigation of the aryl hydrocarbon receptor and the intrinsic tumoral component of the kynurenine pathway of tryptophan metabolism in primary brain tumors"],"prefix":"10.1007","volume":"139","author":[{"given":"Anthony R.","family":"Guastella","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sharon K.","family":"Michelhaugh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Neil V.","family":"Klinger","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hassan A.","family":"Fadel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sam","family":"Kiousis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rouba","family":"Ali-Fehmi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"William J.","family":"Kupsky","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Csaba","family":"Juh\u00e1sz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6435-6821","authenticated-orcid":false,"given":"Sandeep","family":"Mittal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2018,4,17]]},"reference":[{"key":"2869_CR1","doi-asserted-by":"publisher","first-page":"v1","DOI":"10.1093\/neuonc\/nox158","volume":"19","author":"QT Ostrom","year":"2017","unstructured":"Ostrom QT, Gittleman H, Liao P, Vecchione-Koval T, Wolinsky Y, Kruchko C, Barnholtz-Sloan JS (2017) CBTRUS statistical report: primary brain and other central nervous system tumors diagnosed in the United States in 2010\u20132014. Neuro Oncol 19:v1\u2013v88. \n                    https:\/\/doi.org\/10.1093\/neuonc\/nox158","journal-title":"Neuro Oncol"},{"key":"2869_CR2","doi-asserted-by":"publisher","DOI":"10.1007\/s12094-017-1631-4","author":"PD Delgado-Lopez","year":"2017","unstructured":"Delgado-Lopez PD, Corrales-Garcia EM, Martino J, Lastra-Aras E, Duenas-Polo MT (2017) Diffuse low-grade glioma: a review on the new molecular classification, natural history and current management strategies. Clin Transl Oncol. \n                    https:\/\/doi.org\/10.1007\/s12094-017-1631-4","journal-title":"Clin Transl Oncol"},{"key":"2869_CR3","doi-asserted-by":"publisher","first-page":"271","DOI":"10.1007\/s11940-008-0030-0","volume":"10","author":"S Mittal","year":"2008","unstructured":"Mittal S, Szlaczky MC, Barger GR (2008) Low-grade gliomas in adults. Curr Treat Options Neurol 10:271\u2013284","journal-title":"Curr Treat Options Neurol"},{"key":"2869_CR4","doi-asserted-by":"publisher","first-page":"987","DOI":"10.1056\/NEJMoa043330","volume":"352","author":"R Stupp","year":"2005","unstructured":"Stupp R, Mason WP, van den Bent MJ, Weller M, Fisher B, Taphoorn MJ, Belanger K, Brandes AA, Marosi C, Bogdahn U, Curschmann J, Janzer RC, Ludwin SK, Gorlia T, Allgeier A, Lacombe D, Cairncross JG, Eisenhauer E, Mirimanoff RO, for the European Organisation for Research and Treatment of Cancer Brain Tumor and Radiotherapy Groups and the National Cancer Institute of Canada Clinical Trials Group (2005) Radiotherapy plus concomitant and adjuvant temozolomide for glioblastoma. N Engl J Med 352:987\u2013996 \n                    https:\/\/doi.org\/10.1056\/NEJMoa043330","journal-title":"N Engl J Med"},{"key":"2869_CR5","doi-asserted-by":"publisher","first-page":"231","DOI":"10.1007\/s11910-009-0034-5","volume":"9","author":"AD Norden","year":"2009","unstructured":"Norden AD, Drappatz J, Wen PY (2009) Advances in meningioma therapy. Curr Neurol Neurosci Rep 9:231\u2013240","journal-title":"Curr Neurol Neurosci Rep"},{"key":"2869_CR6","doi-asserted-by":"publisher","first-page":"315","DOI":"10.1007\/s11060-011-0741-z","volume":"107","author":"MC Chamberlain","year":"2012","unstructured":"Chamberlain MC (2012) Hydroxyurea for recurrent surgery and radiation refractory high-grade meningioma. J Neurooncol 107:315\u2013321. \n                    https:\/\/doi.org\/10.1007\/s11060-011-0741-z","journal-title":"J Neurooncol"},{"key":"2869_CR7","doi-asserted-by":"publisher","first-page":"981","DOI":"10.1016\/j.ncl.2016.06.014","volume":"34","author":"KA McNeill","year":"2016","unstructured":"McNeill KA (2016) Epidemiology of brain tumors. Neurol Clin 34:981\u2013998. \n                    https:\/\/doi.org\/10.1016\/j.ncl.2016.06.014","journal-title":"Neurol Clin"},{"key":"2869_CR8","doi-asserted-by":"publisher","first-page":"1575","DOI":"10.1093\/neuonc\/nou147","volume":"16","author":"Q Xie","year":"2014","unstructured":"Xie Q, Mittal S, Berens ME (2014) Targeting adaptive glioblastoma: an overview of proliferation and invasion. Neuro Oncol 16:1575\u20131584. \n                    https:\/\/doi.org\/10.1093\/neuonc\/nou147","journal-title":"Neuro Oncol"},{"key":"2869_CR9","doi-asserted-by":"publisher","first-page":"646","DOI":"10.1016\/j.cell.2011.02.013","volume":"144","author":"D Hanahan","year":"2011","unstructured":"Hanahan D, Weinberg RA (2011) Hallmarks of cancer: the next generation. Cell 144:646\u2013674. \n                    https:\/\/doi.org\/10.1016\/j.cell.2011.02.013","journal-title":"Cell"},{"key":"2869_CR10","doi-asserted-by":"publisher","first-page":"e112945","DOI":"10.1371\/journal.pone.0112945","volume":"9","author":"S Adams","year":"2014","unstructured":"Adams S, Teo C, McDonald KL, Zinger A, Bustamante S, Lim CK, Sundaram G, Braidy N, Brew BJ, Guillemin GJ (2014) Involvement of the kynurenine pathway in human glioma pathophysiology. PLoS ONE 9:e112945. \n                    https:\/\/doi.org\/10.1371\/journal.pone.0112945","journal-title":"PLoS ONE"},{"key":"2869_CR11","doi-asserted-by":"publisher","first-page":"197","DOI":"10.1038\/nature10491","volume":"478","author":"CA Opitz","year":"2011","unstructured":"Opitz CA, Litzenburger UM, Sahm F, Ott M, Tritschler I, Trump S, Schumacher T, Jestaedt L, Schrenk D, Weller M, Jugold M, Guillemin GJ, Miller CL, Lutz C, Radlwimmer B, Lehmann I, von Deimling A, Wick W, Platten M (2011) An endogenous tumour-promoting ligand of the human aryl hydrocarbon receptor. Nature 478:197\u2013203. \n                    https:\/\/doi.org\/10.1038\/nature10491","journal-title":"Nature"},{"key":"2869_CR12","doi-asserted-by":"publisher","first-page":"460","DOI":"10.1007\/s11307-009-0225-0","volume":"11","author":"CE Batista","year":"2009","unstructured":"Batista CE, Juh\u00e1sz C, Muzik O, Kupsky WJ, Barger G, Chugani HT, Mittal S, Sood S, Chakraborty PK, Chugani DC (2009) Imaging correlates of differential expression of indoleamine 2,3-dioxygenase in human brain tumors. Mol Imaging Biol 11:460\u2013466. \n                    https:\/\/doi.org\/10.1007\/s11307-009-0225-0","journal-title":"Mol Imaging Biol"},{"key":"2869_CR13","doi-asserted-by":"publisher","DOI":"10.1177\/1536012116644881","author":"AR Guastella","year":"2016","unstructured":"Guastella AR, Michelhaugh SK, Klinger NV, Kupsky WJ, Polin LA, Muzik O, Juh\u00e1sz C, Mittal S (2016) Tryptophan PET Imaging of the Kynurenine pathway in patient-derived xenograft models of glioblastoma. Mol Imaging. \n                    https:\/\/doi.org\/10.1177\/1536012116644881","journal-title":"Mol Imaging"},{"key":"2869_CR14","doi-asserted-by":"publisher","first-page":"69","DOI":"10.1007\/s11060-016-2225-7","volume":"130","author":"NK Talari","year":"2016","unstructured":"Talari NK, Panigrahi M, Madigubba S, Challa S, Phanithi PB (2016) Altered tryptophan metabolism in human meningioma. J Neurooncol 130:69\u201377. \n                    https:\/\/doi.org\/10.1007\/s11060-016-2225-7","journal-title":"J Neurooncol"},{"key":"2869_CR15","doi-asserted-by":"publisher","first-page":"345","DOI":"10.1007\/978-1-4684-5952-4_32","volume":"294","author":"JC Peters","year":"1991","unstructured":"Peters JC (1991) Tryptophan nutrition and metabolism: an overview. Adv Exp Med Biol 294:345\u2013358","journal-title":"Adv Exp Med Biol"},{"key":"2869_CR16","doi-asserted-by":"publisher","DOI":"10.1177\/1178646917691938","author":"AA Badawy","year":"2017","unstructured":"Badawy AA (2017) Kynurenine pathway of tryptophan metabolism: regulatory and functional aspects. Int J Tryptophan Res. \n                    https:\/\/doi.org\/10.1177\/1178646917691938","journal-title":"Int J Tryptophan Res"},{"key":"2869_CR17","doi-asserted-by":"publisher","first-page":"459","DOI":"10.1084\/jem.20020121","volume":"196","author":"G Frumento","year":"2002","unstructured":"Frumento G, Rotondo R, Tonetti M, Damonte G, Benatti U, Ferrara GB (2002) Tryptophan-derived catabolites are responsible for inhibition of T and natural killer cell proliferation induced by indoleamine 2,3-dioxygenase. J Exp Med 196:459\u2013468","journal-title":"J Exp Med"},{"key":"2869_CR18","doi-asserted-by":"publisher","first-page":"6752","DOI":"10.4049\/jimmunol.176.11.6752","volume":"176","author":"F Fallarino","year":"2006","unstructured":"Fallarino F, Grohmann U, You S, McGrath BC, Cavener DR, Vacca C, Orabona C, Bianchi R, Belladonna ML, Volpi C, Santamaria P, Fioretti MC, Puccetti P (2006) The combined effects of tryptophan starvation and tryptophan catabolites down-regulate T cell receptor zeta-chain and induce a regulatory phenotype in naive T cells. J Immunol 176:6752\u20136761","journal-title":"J Immunol"},{"key":"2869_CR19","doi-asserted-by":"publisher","first-page":"1269","DOI":"10.1038\/nm934","volume":"9","author":"C Uyttenhove","year":"2003","unstructured":"Uyttenhove C, Pilotte L, Theate I, Stroobant V, Colau D, Parmentier N, Boon T, Van den Eynde BJ (2003) Evidence for a tumoral immune resistance mechanism based on tryptophan degradation by indoleamine 2,3-dioxygenase. Nat Med 9:1269\u20131274. \n                    https:\/\/doi.org\/10.1038\/nm934","journal-title":"Nat Med"},{"key":"2869_CR20","doi-asserted-by":"publisher","first-page":"365","DOI":"10.1007\/s11060-011-0750-y","volume":"107","author":"B Alkonyi","year":"2012","unstructured":"Alkonyi B, Mittal S, Zitron I, Chugani DC, Kupsky WJ, Muzik O, Chugani HT, Sood S, Juh\u00e1sz C (2012) Increased tryptophan transport in epileptogenic dysembryoplastic neuroepithelial tumors. J Neurooncol 107:365\u2013372. \n                    https:\/\/doi.org\/10.1007\/s11060-011-0750-y","journal-title":"J Neurooncol"},{"key":"2869_CR21","doi-asserted-by":"publisher","first-page":"926","DOI":"10.1016\/j.nucmedbio.2012.01.010","volume":"39","author":"C Juh\u00e1sz","year":"2012","unstructured":"Juh\u00e1sz C, Nahleh Z, Zitron I, Chugani DC, Janabi MZ, Bandyopadhyay S, Ali-Fehmi R, Mangner TJ, Chakraborty PK, Mittal S, Muzik O (2012) Tryptophan metabolism in breast cancers: molecular imaging and immunohistochemistry studies. Nucl Med Biol 39:926\u2013932. \n                    https:\/\/doi.org\/10.1016\/j.nucmedbio.2012.01.010","journal-title":"Nucl Med Biol"},{"key":"2869_CR22","doi-asserted-by":"publisher","first-page":"333","DOI":"10.4161\/cbt.23624","volume":"14","author":"IM Zitron","year":"2013","unstructured":"Zitron IM, Kamson DO, Kiousis S, Juh\u00e1sz C, Mittal S (2013) In vivo metabolism of tryptophan in meningiomas is mediated by indoleamine 2,3-dioxygenase 1. Cancer Biol Ther 14:333\u2013339. \n                    https:\/\/doi.org\/10.4161\/cbt.23624","journal-title":"Cancer Biol Ther"},{"key":"2869_CR23","doi-asserted-by":"publisher","first-page":"3190","DOI":"10.4049\/jimmunol.0903670","volume":"185","author":"JD Mezrich","year":"2010","unstructured":"Mezrich JD, Fechner JH, Zhang X, Johnson BP, Burlingham WJ, Bradfield CA (2010) An interaction between kynurenine and the aryl hydrocarbon receptor can generate regulatory T cells. J Immunol 185:3190\u20133198. \n                    https:\/\/doi.org\/10.4049\/jimmunol.0903670","journal-title":"J Immunol"},{"key":"2869_CR24","doi-asserted-by":"publisher","first-page":"89","DOI":"10.1093\/toxsci\/kfq024","volume":"115","author":"BC DiNatale","year":"2010","unstructured":"DiNatale BC, Murray IA, Schroeder JC, Flaveny CA, Lahoti TS, Laurenzana EM, Omiecinski CJ, Perdew GH (2010) Kynurenic acid is a potent endogenous aryl hydrocarbon receptor ligand that synergistically induces interleukin-6 in the presence of inflammatory signaling. Toxicol Sci 115:89\u201397. \n                    https:\/\/doi.org\/10.1093\/toxsci\/kfq024","journal-title":"Toxicol Sci"},{"key":"2869_CR25","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1093\/toxsci\/kft128","volume":"135","author":"S Safe","year":"2013","unstructured":"Safe S, Lee SO, Jin UH (2013) Role of the aryl hydrocarbon receptor in carcinogenesis and potential as a drug target. Toxicol Sci 135:1\u201316. \n                    https:\/\/doi.org\/10.1093\/toxsci\/kft128","journal-title":"Toxicol Sci"},{"key":"2869_CR26","doi-asserted-by":"publisher","first-page":"1038","DOI":"10.18632\/oncotarget.1637","volume":"5","author":"UM Litzenburger","year":"2014","unstructured":"Litzenburger UM, Opitz CA, Sahm F, Rauschenbach KJ, Trump S, Winter M, Ott M, Ochs K, Lutz C, Liu X, Anastasov N, Lehmann I, Hofer T, von Deimling A, Wick W, Platten M (2014) Constitutive IDO expression in human cancer is sustained by an autocrine signaling loop involving IL-6, STAT3 and the AHR. Oncotarget 5:1038\u20131051","journal-title":"Oncotarget"},{"key":"2869_CR27","doi-asserted-by":"publisher","first-page":"331","DOI":"10.1016\/j.bbrc.2008.07.156","volume":"375","author":"CF Vogel","year":"2008","unstructured":"Vogel CF, Goth SR, Dong B, Pessah IN, Matsumura F (2008) Aryl hydrocarbon receptor signaling mediates expression of indoleamine 2,3-dioxygenase. Biochem Biophys Res Commun 375:331\u2013335. \n                    https:\/\/doi.org\/10.1016\/j.bbrc.2008.07.156","journal-title":"Biochem Biophys Res Commun"},{"key":"2869_CR28","doi-asserted-by":"publisher","first-page":"609","DOI":"10.1038\/nrd870","volume":"1","author":"TW Stone","year":"2002","unstructured":"Stone TW, Darlington LG (2002) Endogenous kynurenines as targets for drug discovery and development. Nat Rev Drug Discov 1:609\u2013620. \n                    https:\/\/doi.org\/10.1038\/nrd870","journal-title":"Nat Rev Drug Discov"},{"key":"2869_CR29","doi-asserted-by":"publisher","first-page":"306","DOI":"10.1186\/s12967-015-0667-x","volume":"13","author":"J Johnson","year":"2015","unstructured":"Johnson J, Ascierto ML, Mittal S, Newsome D, Kang L, Briggs M, Tanner K, Marincola FM, Berens ME, Vande Woude GF, Xie Q (2015) Genomic profiling of a hepatocyte growth factor-dependent signature for MET-targeted therapy in glioblastoma. J Transl Med 13:306. \n                    https:\/\/doi.org\/10.1186\/s12967-015-0667-x","journal-title":"J Transl Med"},{"key":"2869_CR30","doi-asserted-by":"publisher","first-page":"2593","DOI":"10.1038\/onc.2009.104","volume":"28","author":"D Gramatzki","year":"2009","unstructured":"Gramatzki D, Pantazis G, Schittenhelm J, Tabatabai G, Kohle C, Wick W, Schwarz M, Weller M, Tritschler I (2009) Aryl hydrocarbon receptor inhibition downregulates the TGF-beta\/Smad pathway in human glioblastoma cells. Oncogene 28:2593\u20132605. \n                    https:\/\/doi.org\/10.1038\/onc.2009.104","journal-title":"Oncogene"},{"key":"2869_CR31","doi-asserted-by":"publisher","first-page":"24","DOI":"10.1016\/j.cotox.2017.01.012","volume":"2","author":"S Safe","year":"2017","unstructured":"Safe S, Cheng Y, Jin UH (2017) The aryl hydrocarbon receptor (AhR) as a drug target for cancer chemotherapy. Curr Opin Toxicol 2:24\u201329. \n                    https:\/\/doi.org\/10.1016\/j.cotox.2017.01.012","journal-title":"Curr Opin Toxicol"},{"key":"2869_CR32","doi-asserted-by":"publisher","first-page":"2497","DOI":"10.1007\/s00204-017-1981-2","volume":"91","author":"SK Kolluri","year":"2017","unstructured":"Kolluri SK, Jin UH, Safe S (2017) Role of the aryl hydrocarbon receptor in carcinogenesis and potential as an anti-cancer drug target. Arch Toxicol 91:2497\u20132513. \n                    https:\/\/doi.org\/10.1007\/s00204-017-1981-2","journal-title":"Arch Toxicol"},{"key":"2869_CR33","doi-asserted-by":"publisher","first-page":"227","DOI":"10.1186\/s12967-015-0596-8","volume":"13","author":"SK Michelhaugh","year":"2015","unstructured":"Michelhaugh SK, Guastella AR, Varadarajan K, Klinger NV, Parajuli P, Ahmad A, Sethi S, Aboukameel A, Kiousis S, Zitron IM, Ebrahim SA, Polin LA, Sarkar FH, Bollig-Fischer A, Mittal S (2015) Development of patient-derived xenograft models from a spontaneously immortal low-grade meningioma cell line, KCI-MENG1. J Transl Med 13:227. \n                    https:\/\/doi.org\/10.1186\/s12967-015-0596-8","journal-title":"J Transl Med"},{"key":"2869_CR34","doi-asserted-by":"publisher","DOI":"10.1101\/pdb.prot4986","author":"AH Fischer","year":"2008","unstructured":"Fischer AH, Jacobson KA, Rose J, Zeller R (2008) Hematoxylin and eosin staining of tissue and cell sections. CSH Protoc. \n                    https:\/\/doi.org\/10.1101\/pdb.prot4986","journal-title":"CSH Protoc"},{"key":"2869_CR35","unstructured":"Howlader N, Noone AM, Krapcho M, Miller D, Bishop K, Kosary CL, Yu M, Ruhl J, Tatalovich Z, Mariotto A, Lewis DR, Chen HS, Feuer EJ, Cronin KA (eds) (2017) SEER cancer statistics review, 1975\u20132014. National Cancer Institute. Bethesda. \n                    https:\/\/seer.cancer.gov\/csr\/1975_2014\/"},{"key":"2869_CR36","first-page":"2629","volume":"31","author":"C Fotopoulou","year":"2011","unstructured":"Fotopoulou C, Sehouli J, Pschowski R, S VONH., Domanska G, Braicu EI, Fusch G, Reinke P, Schefold JC (2011) Systemic changes of tryptophan catabolites via the indoleamine-2,3-dioxygenase pathway in primary cervical cancer. Anticancer Res 31:2629\u20132635","journal-title":"Anticancer Res"},{"key":"2869_CR37","doi-asserted-by":"publisher","first-page":"66540","DOI":"10.18632\/oncotarget.11658","volume":"7","author":"JF Trott","year":"2016","unstructured":"Trott JF, Kim J, Abu Aboud O, Wettersten H, Stewart B, Berryhill G, Uzal F, Hovey RC, Chen CH, Anderson K, Graef A, Sarver AL, Modiano JF, Weiss RH (2016) Inhibiting tryptophan metabolism enhances interferon therapy in kidney cancer. Oncotarget 7:66540\u201366557. \n                    https:\/\/doi.org\/10.18632\/oncotarget.11658","journal-title":"Oncotarget"},{"key":"2869_CR38","doi-asserted-by":"publisher","first-page":"67","DOI":"10.1016\/j.trsl.2015.07.003","volume":"167","author":"S Santhanam","year":"2016","unstructured":"Santhanam S, Alvarado DM, Ciorba MA (2016) Therapeutic targeting of inflammation and tryptophan metabolism in colon and gastrointestinal cancer. Transl Res 167:67\u201379. \n                    https:\/\/doi.org\/10.1016\/j.trsl.2015.07.003","journal-title":"Transl Res"},{"key":"2869_CR39","doi-asserted-by":"publisher","first-page":"6506","DOI":"10.18632\/oncotarget.6467","volume":"7","author":"B Heng","year":"2016","unstructured":"Heng B, Lim CK, Lovejoy DB, Bessede A, Gluch L, Guillemin GJ (2016) Understanding the role of the kynurenine pathway in human breast cancer immunobiology. Oncotarget 7:6506\u20136520. \n                    https:\/\/doi.org\/10.18632\/oncotarget.6467","journal-title":"Oncotarget"},{"key":"2869_CR40","doi-asserted-by":"publisher","first-page":"4651","DOI":"10.1158\/0008-5472.CAN-15-2011","volume":"75","author":"NC D\u2019Amato","year":"2015","unstructured":"D\u2019Amato NC, Rogers TJ, Gordon MA, Greene LI, Cochrane DR, Spoelstra NS, Nemkov TG, D\u2019Alessandro A, Hansen KC, Richer JK (2015) A TDO2-AhR signaling axis facilitates anoikis resistance and metastasis in triple-negative breast cancer. Cancer Res 75:4651\u20134664. \n                    https:\/\/doi.org\/10.1158\/0008-5472.CAN-15-2011","journal-title":"Cancer Res"},{"key":"2869_CR41","doi-asserted-by":"publisher","first-page":"461","DOI":"10.1158\/1055-9965.EPI-13-0770","volume":"23","author":"SC Chuang","year":"2014","unstructured":"Chuang SC, Fanidi A, Ueland PM, Relton C, Midttun O, Vollset SE, Gunter MJ, Seckl MJ, Travis RC, Wareham N, Trichopoulou A, Lagiou P, Trichopoulos D, Peeters PH, Bueno-de-Mesquita HB, Boeing H, Wientzek A, Kuehn T, Kaaks R, Tumino R, Agnoli C, Palli D, Naccarati A, Aicua EA, Sanchez MJ, Quiros JR, Chirlaque MD, Agudo A, Johansson M, Grankvist K, Boutron-Ruault MC, Clavel-Chapelon F, Fagherazzi G, Weiderpass E, Riboli E, Brennan PJ, Vineis P, Johansson M (2014) Circulating biomarkers of tryptophan and the kynurenine pathway and lung cancer risk. Cancer Epidemiol Biomark Prev 23:461\u2013468. \n                    https:\/\/doi.org\/10.1158\/1055-9965.EPI-13-0770","journal-title":"Cancer Epidemiol Biomark Prev"},{"key":"2869_CR42","doi-asserted-by":"publisher","first-page":"197","DOI":"10.1007\/s00702-011-0681-y","volume":"119","author":"Y Mandi","year":"2012","unstructured":"Mandi Y, Vecsei L (2012) The kynurenine system and immunoregulation. J Neural Transm 119:197\u2013209. \n                    https:\/\/doi.org\/10.1007\/s00702-011-0681-y","journal-title":"J Neural Transm"},{"key":"2869_CR43","doi-asserted-by":"publisher","first-page":"1284","DOI":"10.1093\/neuonc\/nov225.38","volume":"17","author":"E Bosny\u00e1k","year":"2015","unstructured":"Bosny\u00e1k E, Kamson DO, Guastella AR, Varadarajan K, Robinette NL, Kupsky WJ, Muzik O, Michelhaugh SK, Mittal S, Juh\u00e1sz C (2015) Molecular imaging correlates of tryptophan metabolism via the kynurenine pathway in human meningiomas. Neuro Oncol 17:1284\u20131292. \n                    https:\/\/doi.org\/10.1093\/neuonc\/nov098","journal-title":"Neuro Oncol"},{"key":"2869_CR44","doi-asserted-by":"publisher","first-page":"796","DOI":"10.1016\/j.fob.2014.09.003","volume":"4","author":"N Tsuji","year":"2014","unstructured":"Tsuji N, Fukuda K, Nagata Y, Okada H, Haga A, Hatakeyama S, Yoshida S, Okamoto T, Hosaka M, Sekine K, Ohtaka K, Yamamoto S, Otaka M, Grave E, Itoh H (2014) The activation mechanism of the aryl hydrocarbon receptor (AhR) by molecular chaperone HSP90. FEBS Open Bio 4:796\u2013803. \n                    https:\/\/doi.org\/10.1016\/j.fob.2014.09.003","journal-title":"FEBS Open Bio"},{"key":"2869_CR45","doi-asserted-by":"publisher","first-page":"556","DOI":"10.1186\/1471-2407-14-556","volume":"14","author":"CF Tsai","year":"2014","unstructured":"Tsai CF, Hsieh TH, Lee JN, Hsu CY, Wang YC, Lai FJ, Kuo KK, Wu HL, Tsai EM, Kuo PL (2014) Benzyl butyl phthalate induces migration, invasion, and angiogenesis of Huh7 hepatocellular carcinoma cells through nongenomic AhR\/G-protein signaling. BMC Cancer 14:556. \n                    https:\/\/doi.org\/10.1186\/1471-2407-14-556","journal-title":"BMC Cancer"},{"key":"2869_CR46","doi-asserted-by":"publisher","first-page":"907","DOI":"10.1021\/tx5005198","volume":"28","author":"UH Jin","year":"2015","unstructured":"Jin UH, Kim SB, Safe S (2015) Omeprazole inhibits pancreatic cancer cell invasion through a nongenomic aryl hydrocarbon receptor pathway. Chem Res Toxicol 28:907\u2013918. \n                    https:\/\/doi.org\/10.1021\/tx5005198","journal-title":"Chem Res Toxicol"},{"key":"2869_CR47","doi-asserted-by":"publisher","first-page":"958","DOI":"10.1172\/JCI64096","volume":"123","author":"E Montecino-Rodriguez","year":"2013","unstructured":"Montecino-Rodriguez E, Berent-Maoz B, Dorshkind K (2013) Causes, consequences, and reversal of immune system aging. J Clin Invest 123:958\u2013965. \n                    https:\/\/doi.org\/10.1172\/JCI64096","journal-title":"J Clin Invest"},{"key":"2869_CR48","doi-asserted-by":"publisher","first-page":"74","DOI":"10.1016\/j.taap.2017.03.012","volume":"323","author":"BJ Moyer","year":"2017","unstructured":"Moyer BJ, Rojas IY, Murray IA, Lee S, Hazlett HF, Perdew GH, Tomlinson CR (2017) Indoleamine 2,3-dioxygenase 1 (IDO1) inhibitors activate the aryl hydrocarbon receptor. Toxicol Appl Pharmacol 323:74\u201380. \n                    https:\/\/doi.org\/10.1016\/j.taap.2017.03.012","journal-title":"Toxicol Appl Pharmacol"}],"container-title":["Journal of Neuro-Oncology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s11060-018-2869-6\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11060-018-2869-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11060-018-2869-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,5,17]],"date-time":"2020-05-17T07:31:03Z","timestamp":1589700663000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s11060-018-2869-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,4,17]]},"references-count":48,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2018,9]]}},"alternative-id":["2869"],"URL":"https:\/\/doi.org\/10.1007\/s11060-018-2869-6","relation":{},"ISSN":["0167-594X","1573-7373"],"issn-type":[{"value":"0167-594X","type":"print"},{"value":"1573-7373","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,4,17]]},"assertion":[{"value":"4 January 2018","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 April 2018","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 April 2018","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"The authors declare that they have no conflict of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}